|
WO1997000449A1
(en)
|
1995-06-14 |
1997-01-03 |
Aberdeen University |
Prognostic and therapeutic system for cancer
|
|
US6300060B1
(en)
|
1995-11-09 |
2001-10-09 |
Dana-Farber Cancer Institute, Inc. |
Method for predicting the risk of prostate cancer morbidity and mortality
|
|
USRE38490E1
(en)
|
1995-11-16 |
2004-04-06 |
Baylor College Of Medicine |
Method for identifying metastatic sequences
|
|
US5712097A
(en)
|
1996-01-19 |
1998-01-27 |
The Johns Hopkins University School Of Medicine |
Tumor suppressor gene, DPC4
|
|
WO1998002748A1
(en)
|
1996-07-15 |
1998-01-22 |
Mayo Foundation For Medical Education And Research |
Methods to detect hk2 polypeptides
|
|
US6479263B1
(en)
|
1996-11-14 |
2002-11-12 |
Baylor College Of Medicine |
Method for detection of micrometastatic prostate cancer
|
|
US6190857B1
(en)
|
1997-03-24 |
2001-02-20 |
Urocor, Inc. |
Diagnosis of disease state using MRNA profiles in peripheral leukocytes
|
|
AU8403098A
(en)
|
1997-07-15 |
1999-02-10 |
Deaconess Hospital |
Reagents and methods for diagnosis and prognosis of proliferative disor ders
|
|
US20020132981A1
(en)
|
1997-12-03 |
2002-09-19 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
FI980488A7
(fi)
|
1998-03-04 |
1999-09-05 |
Arctic Partners Oy Ab |
Uusi diagnostinen menetelmä
|
|
WO1999064627A2
(en)
|
1998-06-06 |
1999-12-16 |
Genostic Pharma Limited |
Probes used for genetic profiling
|
|
GB2339200B
(en)
|
1998-06-06 |
2001-09-12 |
Genostic Pharma Ltd |
Genostics
|
|
US6902892B1
(en)
|
1998-10-19 |
2005-06-07 |
Diadexus, Inc. |
Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
|
|
AU1853600A
(en)
|
1999-01-06 |
2000-07-24 |
Choong-Chin Liew |
Method for the detection of gene transcripts in blood and uses thereof
|
|
CA2360073C
(en)
*
|
1999-01-28 |
2011-01-18 |
Gen-Probe Incorporated |
Probes and primers for detecting prostate specific antigen (psa) in a biological sample
|
|
US20030207808A1
(en)
|
1999-02-18 |
2003-11-06 |
Kinneret Savitzky |
Novel nucleic acid and amino acid sequences
|
|
FI990382A0
(fi)
*
|
1999-02-23 |
1999-02-23 |
Arctic Partners Oy Ab |
Uusi diagnostinen menetelmä
|
|
EP1176198A4
(en)
|
1999-04-09 |
2002-10-30 |
Chugai Pharmaceutical Co Ltd |
FETAL GENES
|
|
US6960439B2
(en)
|
1999-06-28 |
2005-11-01 |
Source Precision Medicine, Inc. |
Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
|
|
US6692916B2
(en)
|
1999-06-28 |
2004-02-17 |
Source Precision Medicine, Inc. |
Systems and methods for characterizing a biological condition or agent using precision gene expression profiles
|
|
GB9926805D0
(en)
|
1999-11-13 |
2000-01-12 |
Zeneca Ltd |
Diagnostic methods
|
|
DK1246917T3
(da)
*
|
2000-01-13 |
2009-06-08 |
Genentech Inc |
Humane Stra6-polypeptider
|
|
US6448086B1
(en)
|
2000-01-18 |
2002-09-10 |
Diagnostic Systems Laboratories, Inc. |
Insulin-like growth factor system and cancer
|
|
US6566130B1
(en)
|
2000-01-28 |
2003-05-20 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Androgen-regulated gene expressed in prostate tissue
|
|
US7700359B2
(en)
|
2000-06-02 |
2010-04-20 |
Novartis Vaccines And Diagnostics, Inc. |
Gene products differentially expressed in cancerous cells
|
|
AU2002214576A1
(en)
|
2000-10-13 |
2002-04-22 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Genes related to development of refractory prostate cancer
|
|
AU2002216009A1
(en)
|
2000-11-03 |
2002-05-15 |
Michael Giesing |
Clinical and functional validation of targets from disseminated cancer cells
|
|
WO2002074156A2
(en)
|
2001-02-02 |
2002-09-26 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of colon cancer
|
|
WO2002079411A2
(en)
|
2001-03-29 |
2002-10-10 |
Van Andel Institute |
Microarray gene expression profiling in clear cell renal cell carcinoma: prognosis and drug target identification
|
|
US20040203012A1
(en)
|
2001-05-25 |
2004-10-14 |
Eleftherios Diamandis |
Method of detecting and monitoring prostate and ovarian cancers
|
|
JP2005503779A
(ja)
|
2001-06-10 |
2005-02-10 |
アイアールエム，エルエルシー |
致死性の高い癌の分子シグネチャー
|
|
AU2002337657A1
(en)
|
2001-07-25 |
2003-02-17 |
Millennium Pharmaceuticals, Inc. |
Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer
|
|
US7700293B2
(en)
|
2001-08-02 |
2010-04-20 |
The Regents Of The University Of Michigan |
Expression profile of prostate cancer
|
|
US7229774B2
(en)
|
2001-08-02 |
2007-06-12 |
Regents Of The University Of Michigan |
Expression profile of prostate cancer
|
|
US20100297657A1
(en)
|
2001-08-02 |
2010-11-25 |
The Regents Of The University Of Michigan |
Expression profile of prostate cancer
|
|
CA2466502A1
(en)
|
2001-11-09 |
2003-05-15 |
Source Precision Medicine, Inc. |
Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
|
|
AU2002357747A1
(en)
|
2001-12-10 |
2003-06-23 |
Millennium Pharmaceuticals Inc. |
Novel genes encoding colon cancer antigens
|
|
US6949342B2
(en)
|
2001-12-21 |
2005-09-27 |
Whitehead Institute For Biomedical Research |
Prostate cancer diagnosis and outcome prediction by expression analysis
|
|
US20030215835A1
(en)
|
2002-01-15 |
2003-11-20 |
Zairen Sun |
Differentially-regulated prostate cancer genes
|
|
US20050112705A1
(en)
|
2002-03-14 |
2005-05-26 |
Laurent Bracco |
Variants of human kallikrein-2 and kallikrein-3 and uses thereof
|
|
AUPS187002A0
(en)
*
|
2002-04-22 |
2002-05-30 |
Queensland University Of Technology |
Condition-specific molecules and uses therefor
|
|
WO2004025258A2
(en)
|
2002-09-10 |
2004-03-25 |
Sydney Kimmel Cancer Center |
Gene segregation and biological sample classification methods
|
|
EP1585433A4
(en)
|
2002-09-25 |
2008-01-23 |
Ge Healthcare Sv Corp |
DETECTION METHODS
|
|
WO2004053106A2
(en)
|
2002-12-05 |
2004-06-24 |
Regulome Corporation |
Profiled regulatory sites useful for gene control
|
|
AU2004209578A1
(en)
|
2003-02-07 |
2004-08-19 |
Diagnocure Inc. |
Method to detect prostate cancer in a sample
|
|
WO2004077942A2
(en)
|
2003-02-28 |
2004-09-16 |
Genpath Pharmaceuticals, Incorporated |
Inducible prostate cancer model
|
|
US20070059697A1
(en)
|
2003-04-15 |
2007-03-15 |
Avalon Pharmaceuticals, Inc |
Determining cancer-linked genes and therapeutic targets using molecular cytogenetic methods
|
|
US7659062B2
(en)
*
|
2003-06-03 |
2010-02-09 |
The Board of Trustee of the University of Arkansas System |
Gene expression profiling of uterine serous papillary carcinomas and ovarian serous papillary tumors
|
|
JP4680898B2
(ja)
|
2003-06-24 |
2011-05-11 |
ジェノミック ヘルス， インコーポレイテッド |
癌再発の可能性の予測
|
|
EP3330875B1
(en)
*
|
2003-07-10 |
2021-12-01 |
Genomic Health, Inc. |
Expression profile algorithm and test for prognosing breast cancer recurrence
|
|
WO2005007830A2
(en)
|
2003-07-14 |
2005-01-27 |
Mayo Foundation For Medical Education And Research |
Methods and compositions for diagnosis, staging and prognosis of prostate cancer
|
|
EP1656542A4
(en)
|
2003-07-29 |
2008-09-03 |
Bristol Myers Squibb Co |
BIOMARKER OF MODULATION CYCLIN-DEPENDENT KINASE
|
|
AU2004298604B2
(en)
|
2003-12-15 |
2010-09-23 |
The Regents Of The University Of California |
Molecular signature of the PTEN tumor suppressor
|
|
JP2008504803A
(ja)
|
2004-01-09 |
2008-02-21 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
遺伝子発現の細胞型特異的パターン
|
|
GB0400976D0
(en)
|
2004-01-16 |
2004-02-18 |
Univ Cambridge Tech |
Methods of diagnosis
|
|
JP2005211023A
(ja)
|
2004-01-30 |
2005-08-11 |
Hayashibara Biochem Lab Inc |
腎細胞癌の転移若しくは再発の可能性を予測する方法
|
|
WO2005076005A2
(en)
|
2004-01-30 |
2005-08-18 |
Medizinische Universität Wien |
A method for classifying a tumor cell sample based upon differential expression of at least two genes
|
|
WO2005083128A2
(en)
|
2004-02-25 |
2005-09-09 |
University Of South Florida |
Methods for predicting cancer outcome and gene signatures for use therein
|
|
US20070224596A1
(en)
|
2004-04-09 |
2007-09-27 |
Mariana Nacht |
Compositions and methods for the modifying hypoxia induced gene regulation
|
|
ES2550614T3
(es)
|
2004-04-09 |
2015-11-11 |
Genomic Health, Inc. |
Marcadores de expresión génica para predecir la respuesta a la quimioterapia
|
|
US8227380B2
(en)
|
2004-04-29 |
2012-07-24 |
Marc Ramael |
Method and kit for detecting components in a sample
|
|
WO2005113816A2
(en)
|
2004-05-07 |
2005-12-01 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Methods of diagnosing or treating prostate cancer using the erg gene, alone or in combination with other over or under expressed genes in prostate cancer
|
|
JP2008500057A
(ja)
|
2004-05-27 |
2008-01-10 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Ｉｍｐｄｈ経路の阻害をモニタリングするためのバイオマーカー
|
|
JP2008502326A
(ja)
|
2004-06-03 |
2008-01-31 |
バイエル・ヘルスケア・アクチェンゲゼルシャフト |
癌治療に対する反応を予測およびモニターする方法
|
|
WO2006005043A2
(en)
|
2004-06-30 |
2006-01-12 |
Cemines, Inc. |
Compositions and methods for detecting protein interactions with target dna sequences
|
|
US7587279B2
(en)
|
2004-07-06 |
2009-09-08 |
Genomic Health |
Method for quantitative PCR data analysis system (QDAS)
|
|
KR20070052788A
(ko)
|
2004-08-13 |
2007-05-22 |
밀레니엄 파머슈티컬스 인코퍼레이티드 |
전립선암의 확인, 평가, 예방 및 요법을 위한 유전자,조성물, 키트 및 방법
|
|
US7572640B2
(en)
|
2004-09-28 |
2009-08-11 |
Singulex, Inc. |
Method for highly sensitive detection of single protein molecules labeled with fluorescent moieties
|
|
CA3061785A1
(en)
*
|
2004-11-05 |
2006-05-18 |
Genomic Health, Inc. |
Predicting response to chemotherapy using gene expression markers
|
|
AU2005308594A1
(en)
|
2004-11-24 |
2006-06-01 |
St George's Enterprises Limited |
Diagnosis of prostate cancer
|
|
WO2006066240A2
(en)
|
2004-12-17 |
2006-06-22 |
Veridex Llc |
Methods for assessing patients with acute myeloid leukemia
|
|
US7943306B2
(en)
|
2005-01-12 |
2011-05-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Gene expression signature for prediction of human cancer progression
|
|
WO2006089087A2
(en)
|
2005-02-17 |
2006-08-24 |
Dana-Farber Cancer Institute, Inc. |
Compositions, kits and methods for identification, assessment, prevention and therapy of cancer
|
|
US7666595B2
(en)
*
|
2005-02-25 |
2010-02-23 |
The Brigham And Women's Hospital, Inc. |
Biomarkers for predicting prostate cancer progression
|
|
AU2006234897A1
(en)
*
|
2005-03-16 |
2006-10-19 |
Sidney Kimmel Cancer Center |
Methods and compositions for predicting death from cancer and prostate cancer survival using gene expression signatures
|
|
WO2006105642A1
(en)
|
2005-04-05 |
2006-10-12 |
British Columbia Cancer Agency |
Biomarkers for the detection of lung cancer and uses thereof
|
|
CA2604689A1
(en)
|
2005-04-15 |
2006-10-26 |
Oncomethylome Sciences, Inc. |
Methylation markers for diagnosis and treatment of cancers
|
|
US20090186024A1
(en)
|
2005-05-13 |
2009-07-23 |
Nevins Joseph R |
Gene Expression Signatures for Oncogenic Pathway Deregulation
|
|
US20080275652A1
(en)
|
2005-05-13 |
2008-11-06 |
Universite Libre De Bruxelles |
Gene-based algorithmic cancer prognosis
|
|
WO2006135596A2
(en)
|
2005-06-06 |
2006-12-21 |
The Regents Of The University Of Michigan |
Prognostic meta signatures and uses thereof
|
|
CA2611728A1
(en)
|
2005-06-08 |
2006-12-14 |
Millennium Pharmaceuticals, Inc. |
Methods for the identification, assessment, and treatment of patients with cancer therapy
|
|
US20070099209A1
(en)
|
2005-06-13 |
2007-05-03 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
US20070105133A1
(en)
|
2005-06-13 |
2007-05-10 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
CA2814598A1
(en)
*
|
2005-09-12 |
2007-03-22 |
The Regents Of The University Of Michigan |
Recurrent gene fusions in prostate cancer
|
|
AU2006339538A1
(en)
|
2005-11-08 |
2007-09-13 |
Euclid Diagnostics Llc |
Materials and methods for assaying for methylation of CpG islands associated with genes in the evaluation of cancer
|
|
CA2631236C
(en)
|
2005-12-01 |
2019-10-29 |
Medical Prognosis Institute |
Methods and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
|
|
US8445198B2
(en)
|
2005-12-01 |
2013-05-21 |
Medical Prognosis Institute |
Methods, kits and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
|
|
CA2630597A1
(en)
|
2005-12-08 |
2007-06-14 |
Novartis Ag |
Effects of inhibitors of fgfr3 on gene transcription
|
|
WO2007070621A2
(en)
|
2005-12-13 |
2007-06-21 |
Children's Medical Center Corporation |
Prognosis indicators for solid human tumors
|
|
WO2007075672A2
(en)
|
2005-12-23 |
2007-07-05 |
Lankenau Institute For Medical Research |
Prognostic cancer markers
|
|
DK1974058T3
(da)
|
2006-01-11 |
2014-09-01 |
Genomic Health Inc |
Genekspressionsmarkører til prognosticering af kolorektal cancer
|
|
ES2300176B1
(es)
*
|
2006-02-15 |
2009-05-01 |
Consejo Superior Investig. Cientificas |
Metodo para el diagnostico molecular de cancer de prostata, kit para implementar el metodo.
|
|
US20070218512A1
(en)
|
2006-02-28 |
2007-09-20 |
Alex Strongin |
Methods related to mmp26 status as a diagnostic and prognostic tool in cancer management
|
|
US7888019B2
(en)
|
2006-03-31 |
2011-02-15 |
Genomic Health, Inc. |
Genes involved estrogen metabolism
|
|
US20090098538A1
(en)
|
2006-03-31 |
2009-04-16 |
Glinsky Gennadi V |
Prognostic and diagnostic method for disease therapy
|
|
US7914988B1
(en)
|
2006-03-31 |
2011-03-29 |
Illumina, Inc. |
Gene expression profiles to predict relapse of prostate cancer
|
|
WO2007140352A2
(en)
|
2006-05-26 |
2007-12-06 |
Invitrogen Corporation |
Plasma membrane and secreted cancer biomarkers
|
|
WO2007149965A2
(en)
|
2006-06-22 |
2007-12-27 |
Wisconsin Alumni Research Foundation |
Stromal collagen in the diagnosis and characterization of breast cancer
|
|
WO2008036717A2
(en)
|
2006-09-19 |
2008-03-27 |
Emory University |
Use of soluble galectin-3 (gal-3) for cancer treatment
|
|
WO2008046510A1
(en)
|
2006-10-16 |
2008-04-24 |
Bayer Healthcare Ag |
Fn1 as a biomarker, therapeutic and diagnostic target
|
|
WO2008048570A2
(en)
|
2006-10-16 |
2008-04-24 |
The Ohio State University Research Foundation |
Piwil2-related biomarkers and cell lines useful therewith
|
|
WO2008067065A2
(en)
*
|
2006-10-19 |
2008-06-05 |
Shiv Srivastava |
Methods, kits, and systems for diagnosing and prognosing prostate cancer using secreted biomarkers
|
|
WO2008058018A2
(en)
|
2006-11-02 |
2008-05-15 |
Mayo Foundation For Medical Education And Research |
Predicting cancer outcome
|
|
JP2010509598A
(ja)
|
2006-11-13 |
2010-03-25 |
ライフ テクノロジーズ コーポレーション |
前立腺癌バイオマーカーを検出するための方法およびキット
|
|
US20080131887A1
(en)
|
2006-11-30 |
2008-06-05 |
Stephan Dietrich A |
Genetic Analysis Systems and Methods
|
|
US20100015620A1
(en)
|
2006-12-06 |
2010-01-21 |
Strovel Jeffrey W |
Cancer-linked genes as biomarkers to monitor response to impdh inhibitors
|
|
AT504702A1
(de)
|
2006-12-22 |
2008-07-15 |
Arc Austrian Res Centers Gmbh |
Set von tumormarkern
|
|
WO2008086342A2
(en)
|
2007-01-09 |
2008-07-17 |
Bristol-Myers Squibb Company |
Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in prostate cells
|
|
US20090047694A1
(en)
|
2007-08-17 |
2009-02-19 |
Shuber Anthony P |
Clinical Intervention Directed Diagnostic Methods
|
|
US20090258795A1
(en)
|
2007-03-15 |
2009-10-15 |
Genomic Health, Inc. |
Gene expression markers for prediction of patient response to chemotherapy
|
|
WO2008122447A2
(en)
|
2007-04-10 |
2008-10-16 |
Epigenomics Ag |
Dna methylation assay for the diagnosis or prognosis of medical conditions
|
|
AU2008251381B2
(en)
|
2007-05-11 |
2014-10-30 |
The Johns Hopkins University |
Biomarkers for melanoma
|
|
EP2068618A4
(en)
|
2007-05-21 |
2011-01-19 |
Dana Farber Cancer Inst Inc |
COMPOSITIONS AND METHODS OF DISCOVERING TUMOR GENES
|
|
WO2009021338A1
(en)
|
2007-08-15 |
2009-02-19 |
UNIVERSITé DE SHERBROOKE |
Alternative splicing gene variants in cancer detection
|
|
JP2010537658A
(ja)
|
2007-09-07 |
2010-12-09 |
ユニヴェルシテ リブル ドゥ ブリュッセル |
Ｈｅｒ２＋患者におけるガンの予後判定のための方法およびツール
|
|
WO2009051734A1
(en)
|
2007-10-17 |
2009-04-23 |
The General Hospital Corporation |
Microchip-based devices for capturing circulating tumor cells and methods of their use
|
|
GB0721605D0
(en)
|
2007-11-02 |
2007-12-12 |
Cancer Rec Tech Ltd |
Prostrate cancer susceptibility screening
|
|
US20090123439A1
(en)
|
2007-11-09 |
2009-05-14 |
The Jackson Laboratory |
Diagnostic and prognosis methods for cancer stem cells
|
|
WO2009070767A2
(en)
|
2007-11-28 |
2009-06-04 |
Whitehead Institute For Biomedical Research |
Systemic instigation systems to study tumor growth or metastasis
|
|
EP2065474A1
(en)
|
2007-11-28 |
2009-06-03 |
Siemens Healthcare Diagnostics GmbH |
A method to assess prognosis and to predict therapeutic response to endocrine treatment
|
|
US9932639B2
(en)
|
2007-11-30 |
2018-04-03 |
Ralph Markus Wirtz |
Method for predicting therapy responsiveness in basal like tumors
|
|
WO2009089521A2
(en)
|
2008-01-10 |
2009-07-16 |
Nuvera Biosciences, Inc. |
Predictors for evaluating response to cancer therapy
|
|
WO2009105154A2
(en)
|
2008-02-19 |
2009-08-27 |
The Jackson Laboratory |
Diagnostic and prognostic methods for cancer
|
|
WO2009105640A1
(en)
|
2008-02-22 |
2009-08-27 |
Virginia Commonwealth University |
Signatures associated with rejection or recurrence of cancer
|
|
US8067178B2
(en)
|
2008-03-14 |
2011-11-29 |
Genomic Health, Inc. |
Gene expression markers for prediction of patient response to chemotherapy
|
|
NZ627239A
(en)
|
2008-03-26 |
2015-12-24 |
Theranos Inc |
Methods and systems for assessing clinical outcomes
|
|
EP2105511A1
(en)
|
2008-03-28 |
2009-09-30 |
Fraunhofer-Gesellschaft zur Förderung der Angewandten Forschung e.V. |
Medicament compositions and substances for treatment and identifying adenocarcinoma of the lung
|
|
US20110053804A1
(en)
|
2008-04-03 |
2011-03-03 |
Sloan-Kettering Institute For Cancer Research |
Gene Signatures for the Prognosis of Cancer
|
|
CA2719172C
(en)
|
2008-04-10 |
2020-08-25 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. |
Prostate cancer-specific alterations in erg8 gene expression and detection and treatment methods based on those alterations
|
|
CA2722424A1
(en)
|
2008-04-25 |
2009-10-29 |
Integrated Bioscience Solutions, Llc |
Cytological methods for detecting cancer
|
|
US8093000B2
(en)
|
2008-05-09 |
2012-01-10 |
The Regents Of The University Of California |
Methods for predicting and treating tumors resistant to drug, immunotherapy, and radiation
|
|
JP2011521215A
(ja)
|
2008-05-14 |
2011-07-21 |
エーテーハー チューリヒ |
前立腺癌の診断及び治療のためのバイオマーカー及び薬剤標的発見法、並びにそれを用いて決定されるバイオマーカーアッセイ
|
|
WO2009139915A2
(en)
|
2008-05-15 |
2009-11-19 |
The University Of North Carolina At Chapel Hill |
Novel targets for regulation of angiogenesis
|
|
WO2009140741A1
(en)
|
2008-05-23 |
2009-11-26 |
The University Of Queensland |
Agents and methods for diagnosing the presence or risk of prostate cancer
|
|
CA2725978A1
(en)
|
2008-05-28 |
2009-12-03 |
Genomedx Biosciences, Inc. |
Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer
|
|
GB0809689D0
(en)
|
2008-05-28 |
2008-07-02 |
Cancer Res Inst Royal |
Markers for prostate cancee
|
|
US20090298082A1
(en)
*
|
2008-05-30 |
2009-12-03 |
Klee George G |
Biomarker panels for predicting prostate cancer outcomes
|
|
WO2009149166A2
(en)
|
2008-06-03 |
2009-12-10 |
Children's Hospital Medical Center |
Methods and compositions for the diagnosis and treatment of proliferative disorders
|
|
WO2010003773A1
(en)
|
2008-06-16 |
2010-01-14 |
Siemens Medical Solutions Diagnostics Gmbh |
Algorithms for outcome prediction in patients with node-positive chemotherapy-treated breast cancer
|
|
CA2730277A1
(en)
|
2008-07-08 |
2010-01-14 |
Source Precision Medicine, Inc. D/B/A Source Mdx |
Gene expression profiling for predicting the survivability of prostate cancer subjects
|
|
JP2011528442A
(ja)
|
2008-07-16 |
2011-11-17 |
ディナ ファーバー キャンサー インスティチュート，インコーポレイテッド |
前立腺癌に関連した兆候およびｐｃｄｅｔｅｒｍｉｎａｎｔ、ならびにそれらの使用方法
|
|
AU2009274563A1
(en)
|
2008-07-21 |
2010-01-28 |
Texas A & M University |
Methods for diagnosis and prognosis of skin cancer
|
|
US9103819B2
(en)
|
2008-09-10 |
2015-08-11 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Peripheral zone tumor cells, methods for their preparation and use
|
|
EP2350316B1
(en)
|
2008-10-20 |
2014-04-16 |
ValiPharma |
Methods and uses involving genetic aberrations of nav3 and aberrant expression of multiple genes
|
|
KR20110073534A
(ko)
|
2008-10-22 |
2011-06-29 |
제넨테크, 인크. |
전립선 줄기 세포 및 그의 용도
|
|
JP2012507300A
(ja)
|
2008-10-30 |
2012-03-29 |
カリス ライフ サイエンシズ ルクセンブルク ホールディングス |
Ｒｎａパターンを評価する方法
|
|
US20110230361A1
(en)
*
|
2008-11-14 |
2011-09-22 |
Emory University |
Prostate cancer biomarkers to predict recurrence and metastatic potential
|
|
WO2010056351A2
(en)
|
2008-11-14 |
2010-05-20 |
Stc.Unm |
Gene expression classifiers for relapse free survival and minimal residual disease improve risk classification and out come prediction in pedeatric b-precursor acute lymphoblastic leukemia
|
|
GB0821787D0
(en)
|
2008-12-01 |
2009-01-07 |
Univ Ulster |
A genomic-based method of stratifying breast cancer patients
|
|
US20110236903A1
(en)
|
2008-12-04 |
2011-09-29 |
Mcclelland Michael |
Materials and methods for determining diagnosis and prognosis of prostate cancer
|
|
CA2748823A1
(en)
|
2009-01-06 |
2010-07-15 |
Source Precision Medicine, Inc. D/B/A Source Mdx |
Gene expression profiling for the identification, monitoring, and treatment of prostate cancer
|
|
EP3118328A1
(en)
|
2009-01-07 |
2017-01-18 |
Myriad Genetics, Inc. |
Cancer biomarkers
|
|
JP5907732B2
(ja)
|
2009-01-14 |
2016-04-26 |
ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
比に基づく生体マーカーおよびそれを使用する方法
|
|
CA2749817A1
(en)
|
2009-01-15 |
2010-07-22 |
Laboratory Corporation Of America Holdings |
Methods of determining patient response by measurement of her-2 expression
|
|
EP2233590A1
(en)
|
2009-01-28 |
2010-09-29 |
AIT Austrian Institute of Technology GmbH |
Methylation assay
|
|
WO2010096734A2
(en)
|
2009-02-20 |
2010-08-26 |
John Wayne Cancer Institute |
B7-h3 antibody coupled bead assay for isolation and detection of circulating tumor cells in body fluids of melanoma and breast cancer patients
|
|
WO2010099577A1
(en)
|
2009-03-04 |
2010-09-10 |
The University Of Queensland |
Cancer biomarkers and uses therefor
|
|
US8639733B2
(en)
|
2009-03-16 |
2014-01-28 |
Apple Inc. |
Automatic identification of compatible applications and accessories
|
|
US8765383B2
(en)
|
2009-04-07 |
2014-07-01 |
Genomic Health, Inc. |
Methods of predicting cancer risk using gene expression in premalignant tissue
|
|
EP2241634A1
(en)
|
2009-04-16 |
2010-10-20 |
Université Libre de Bruxelles |
Diagnostic method and tools to predict the effiacy of targeted agents against IGF-1 pathway activation in cancer
|
|
CN105132544A
(zh)
|
2009-04-16 |
2015-12-09 |
加拿大国家研究委员会 |
用于肿瘤特征和标记物组鉴定，肿瘤分级的方法和用于癌的标记物组
|
|
WO2010127399A1
(en)
|
2009-05-06 |
2010-11-11 |
Walter And Eliza Hall Institute Of Medical Research |
Gene expression profiles and uses thereof
|
|
WO2010129965A1
(en)
|
2009-05-08 |
2010-11-11 |
The Regents Of The University Of California |
Cancer specific mitotic network
|
|
US20100303795A1
(en)
*
|
2009-05-27 |
2010-12-02 |
Soerensen Karina Dalsgaard |
Marker of prostate cancer
|
|
AU2010270227B2
(en)
|
2009-07-08 |
2015-01-22 |
Worldwide Innovative Network |
Method for predicting efficacy of drugs in a patient
|
|
WO2011039734A2
(en)
|
2009-10-02 |
2011-04-07 |
Enzo Medico |
Use of genes involved in anchorage independence for the optimization of diagnosis and treatment of human cancer
|
|
CA2776751C
(en)
|
2009-11-23 |
2019-07-02 |
Genomic Health, Inc. |
Methods to predict clinical outcome of cancer
|
|
EP2524055A4
(en)
|
2010-01-11 |
2013-06-05 |
Genomic Health Inc |
METHOD FOR THE USE OF GENE EXPRESSION FOR DETERMINING THE PROBABILITY OF CLINICAL EXERCISE OF KIDNEY CANCER
|
|
EP2913405B1
(en)
|
2010-07-27 |
2016-11-09 |
Genomic Health, Inc. |
Method for using gene expression to determine prognosis of prostate cancer
|
|
WO2014108896A1
(en)
|
2013-01-08 |
2014-07-17 |
Marpe Technologies Ltd. |
Device and method for body moles mapping and tracking
|